ongoing challenge in the standard of care worldwide. Incorporating study sites at the crossroads of three continents will help provide a more representative overall patient population for the evaluation of RLS-1496 in this important condition.” “At...
is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help detect and fight tumor cells. KEYTRUDA is a humanized monoclonal antibody that blocks the interaction between PD-1 and...
Chemputation—Chemify’s purpose-built AI to digitize molecule creation—has raised over $50 million in Series B funding to help accelerate its mission of becoming the global leader in digital chemistry, molecular design and manufacturing. The...
delays and increase the risk of some childhood cancers. Deep and rapid insights from whole-genome sequencing can help researchers understand and better identify potential treatments for these hard-to-diagnose conditions. Constellation is emerging...
of CTIBIOTECH™, emphasized the strategic importance of this agreement: "Working alongside CILCARE and SATT AxLR, we are helping to develop tools that will accelerate the discovery of treatments for hearing pathologies affecting more than 1 billion...
device with real-time adjustments that make it easy to use in critical moments. The device also features ZOLL’s Real BVM Help® and exclusive Real CPR Help® technology. ZOLL has been a major source of growth for Asahi Kasei’s Healthcare sector,...
single-cell multi-omics platform carries the same potential to shift standards in precision medicine, and I am eager to help extend its impact across cancer, cell and gene therapy, and therapeutic development.” Mission Bio’s Tapestri Platform is...
widespread anxiety, she believes, is moving from a 'wait-and-see' mindset to proactive education and enablement. By helping employees understand that AI is a tool for efficiency, not a threat to their jobs, organizations can unlock its...
journey, from initiation through maintenance therapy. In addition to the current resources already provided (e.g., help with understanding insurance coverage and potential out-of-pocket costs and identifying financial support programs), the new...
injections or lab monitoring. It is the first FDA-approved Bruton's tyrosine kinase inhibitor (BTKi) for CSU. Rhapsido helps to inhibit the release of histamine and other proinflammatory mediators by targeting BTK, offering a unique approach to CSU...
symptoms in the real world among patients receiving up to 12 months of treatment with DAYBUE. “These findings from LOTUS help deepen our understanding of the potential outcomes associated with long-term treatment of DAYBUE in the real-world...
or targeted therapies in preclinical models. TTFields therapy provides clinical versatility that has the potential to help address treatment challenges across a range of solid tumors. About Novocure: Novocure is a global oncology company working to...
basket study, which includes BRAF V600 altered thyroid cancers, as we aim to generate further data to inform treatment and help patients with BRAF driven tumors.” The results presented at ATA 2025 are from 21 patients with thyroid cancer, 16 with...
can also be used as radioactive tracers in medical imaging, enhancing accuracy and providing detailed insights to help improve diagnosis. The strategic global collaboration between MDC and Crown Bioscience supports companies across the...
therapy, with Hims & Hers’ ability to reach and educate millions of men, we are breaking down barriers to care and helping to ensure patients can access innovative treatment in a convenient and trusted way.” Andrew Dudum, CEO of Hims & Hers added,...
system means patients do not have to worry about not waking up and missing their second dose. The single bedtime dose helps assure patients receive the full therapeutic benefit of their medication every night, demonstrated in the REFRESH study to...
long-term data emphasize impressive PFS and durability of response, with a tolerable and manageable safety profile that helps patients stay on therapy so they can continue to benefit. We remain excited about the promise of IBTROZI and look forward...
has a low five-year survival rate.1,2 While conventional standard of care treatments for patients with advanced SCLC may help improve outcomes, there is a need for additional subsequent treatment approaches.3,4,5,6 In August 2025, ifinatamab...
of Swine at Boehringer Ingelheim. “We’ll continue to closely monitor PCV2 and other diseases impacting pig performance to help producers stay ahead of emerging risks.” A vaccine that provides broad cross-protection is essential for effective PCV2...
iPSC manufacturing with a closed, automated system that enables consistent, GMP-compatible production of human iPSC cells, helping biotech companies reduce cost, variability, and time to clinic. With these recent partnerships, Mytos is enabling...
